Featured Research

from universities, journals, and other organizations

One Dose Of Hormone May Halt Cell Suicide Following A Heart Attack, Study Suggests

Date:
October 10, 2008
Source:
Society of Nuclear Medicine
Summary:
Two things happen following a heart attack--necrosis (normal cell death) and apoptosis (programmed cell death) -- and both are bad. Now researchers in Japan have found that a single intravenous dose of the hormone erythropoietin immediately after myocardial infarction (heart attack) can drastically reduce or eliminate apoptosis and thereby limit the amount of damage to the heart, according to an article in the Journal of Nuclear Medicine.

Two things happen following a heart attack—necrosis (normal cell death) and apoptosis (programmed cell death)—and both are bad. Now researchers in Japan have found that a single intravenous dose of the hormone erythropoietin (EPO) immediately after myocardial infarction (heart attack) can drastically reduce or eliminate apoptosis and thereby limit the amount of damage to the heart, according to a new article.

"The study's concept is very novel. We wanted to see if the area of cell death following acute coronary occlusion could be reduced by a single dose of EPO," said H William. Strauss, M.D., attending physician in the Nuclear Medicine Service at Memorial Sloan Kettering Cancer Center, professor of radiology at Weill Cornell School of Medicine and a co-author of the manuscript. "Cells deprived of blood quickly begin to die. By administering 99mTc-annexin V, a radiotracer with a high affinity for apoptotic cells, we were able to view the effects of EPO on heart cells immediately following the restriction of blood flow that occurs during MI."

In the study, 18 Wistar rats were randomized into two groups. In both groups, arteries were blocked to induce a heart attack; 20 minutes later, they were unblocked. Immediately afterward, one group (treatment) received an injection of EPO and the other group of saline (non-treatment). Both groups were then injected with 99mTc-annexin V, and their hearts were examined using autoradiography to evaluate the distribution of the radiotracer. In the treatment group, EPO therapy caused a 2.7-fold reduction of tracer accumulation, indicating a reduction in apoptosis and, therefore, less damage to heart tissue. The reduction in damage to the heart was also demonstrated by measurement of regional cardiac function, which was significantly better in the EPO-treated group. These findings suggest that EPO may be useful to prevent long-term heart damage and dysfunction after a heart attack.

"Although other drugs to inhibit apoptosis have been studied, none appears nearly as effective as a single dose of EPO," Strauss said.

EPO is a naturally occurring hormone that promotes the formation of red blood cells in the bone marrow. It was first produced artificially to aid in the treatment of anemia. More recently, scientists discovered its cardioprotective capability in minimizing apoptosis.

Apoptosis is sometimes referred to as "cell suicide," because the biochemically programmed mechanism triggers damaged cells to self-destruct, albeit in an orderly way. Researchers have found that cells can die by several pathways, only one of which is apoptosis. Because cell death is central to normal physiology and numerous disease states, research into apoptosis is ongoing in a variety of medical areas, including oncology and cardiology.

"In cardiovascular medicine, imaging of apoptosis could be highly useful in managing myocardial infarction, atherosclerotic plaques [hardening of the arteries] and cardiac allograft rejection [heart transplant rejection]. Because molecular probes such as 99mTc-annexin V are capable of imaging apoptosis in living patients, they are vital to this research," said Robert W. Atcher, Ph.D., president of SNM, an international scientific and medical association dedicated to advancing molecular imaging and therapy.

"More translational research is needed to evaluate cell death pathways and their significance for imaging in the diagnosis or monitoring of disease. SNM is currently working with molecular imaging practitioners, government agencies and pharmaceutical manufacturers to streamline the process to progress promising molecular imaging agents from the laboratory into the clinical setting, " Atcher added.


Story Source:

The above story is based on materials provided by Society of Nuclear Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Doue et al. Cardioprotective Effects of Erythropoietin in Rats Subjected to Ischemia-Reperfusion Injury: Assessment of Infarct Size with 99mTc-Annexin V. Journal of Nuclear Medicine, 2008; 49 (10): 1694 DOI: 10.2967/jnumed.107.050260

Cite This Page:

Society of Nuclear Medicine. "One Dose Of Hormone May Halt Cell Suicide Following A Heart Attack, Study Suggests." ScienceDaily. ScienceDaily, 10 October 2008. <www.sciencedaily.com/releases/2008/10/081008114359.htm>.
Society of Nuclear Medicine. (2008, October 10). One Dose Of Hormone May Halt Cell Suicide Following A Heart Attack, Study Suggests. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2008/10/081008114359.htm
Society of Nuclear Medicine. "One Dose Of Hormone May Halt Cell Suicide Following A Heart Attack, Study Suggests." ScienceDaily. www.sciencedaily.com/releases/2008/10/081008114359.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins